Study guide
12.4 Professional Development, Precepting, and ICU Pharmacy Services
Board Certified Critical Care Pharmacist Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Pathophysiology and Recognition of Critical Illness
1.1 Pathophysiology of Shock and Sepsis 1.2 Respiratory Failure and ARDS Pathophysiology 1.3 ICU-Acquired Weakness and Post-Intensive Care Syndrome 1.4 Chronic Disease States and Risk Factors for Critical Illness
2 Chapter 2: Medical Devices and Circulatory Support
2.1 Hemodynamic Monitoring and Interpretation 2.2 Mechanical Circulatory Support 2.3 Mechanical Ventilation Modes and Settings 2.4 Continuous Renal Replacement Therapy 2.5 Lines, Tubes, and Drains in Critical Care
3 Chapter 3: Fluid, Electrolyte, and Acid-Base Management
3.1 Resuscitation Fluids: Crystalloids vs. Colloids 3.2 Electrolyte Disorders in the ICU 3.3 Acid-Base Disorders and Interpretation
4 Chapter 4: Vasoactive and Inotropic Therapy in Shock
4.1 Vasopressors in Distributive Shock 4.2 Inotropes and Vasopressors in Cardiogenic and Obstructive Shock
5 Chapter 5: Sedation, Analgesia, and Delirium (PADIS)
5.1 Pain and Analgesia in the ICU 5.2 Sedation Strategies and Medication Selection 5.3 Delirium Assessment, Prevention, and Treatment 5.4 Neuromuscular Blockade in Critical Illness
6 Chapter 6: Cardiovascular Emergencies
6.1 Acute Coronary Syndromes in ICU Patients 6.2 Acute Decompensated Heart Failure 6.3 Hypertensive Emergencies and Arrhythmias
7 Chapter 7: Pulmonary and Infectious Diseases in the ICU
7.1 Severe Sepsis and Septic Shock Antimicrobial Selection 7.2 Pharmacotherapy for Mechanical Ventilation and ARDS 7.3 Severe Infections in the ICU
8 Chapter 8: Neurocritical Care
8.1 Ischemic and Hemorrhagic Stroke Management 8.2 Intracranial Hypertension and Brain Edema 8.3 Status Epilepticus and Sedation in Brain Injury
9 Chapter 9: Toxicology, Endocrine, and Hematologic Emergencies
9.1 Toxicology and Antidote Therapy in the ICU 9.2 Endocrine Emergencies 9.3 Hematologic Emergencies, Anticoagulant Reversal, and Transfusions 9.4 Gastrointestinal and Hepatic Emergencies in the ICU 9.5 Dermatologic and Immunologic Conditions in the ICU 9.6 Trauma, Burns, Supportive Care, and End-of-Life Pharmacotherapy
10 Chapter 10: Special Populations, Pharmacokinetics, and Nutrition
10.1 Altered Pharmacokinetics in Critically Ill Patients 10.2 Therapeutic Drug Monitoring in the ICU 10.3 Nutrition Support: Enteral vs. Parenteral
11 Chapter 11: Quality, Safety, and Clinical Guidelines
11.1 Medication Safety and Error Prevention in the ICU 11.2 Antimicrobial Stewardship and Infection Prevention 11.3 Implementation of Clinical Practice Guidelines 11.4 Healthcare Regulations, Standards, and Drug Interactions
12 Chapter 12: Practice Management, Biostatistics, and Evidence-Based Medicine
12.1 ICU Formulary Management and Cost-Effectiveness 12.2 Biostatistics and Literature Evaluation 12.3 Clinical Trial Interpretation in Critical Care 12.4 Professional Development, Precepting, and ICU Pharmacy Services 12.5 Alternative ICU Delivery Models and Disaster Healthcare Management
13 Chapter 13: Treatment Planning and Care Coordination
13.1 Goals of Care, Perioperative Care, and Transitions of Care 13.2 Medication Delivery Routes and Devices in Critical Illness 13.3 Social Determinants of Health and Patient/Caregiver Education
12.4 Professional Development, Precepting, and ICU Pharmacy Services
Key Takeaways Explain This Topic AI
The four roles of a preceptor (direct instruction, modeling, coaching, and facilitating) must be tailored to the learner's stage of development.
Constructive feedback should be specific, timely, actionable, and focused on behaviors rather than personal attributes.
Credentialing and privileging ensure pharmacists have the documented competence to perform advanced clinical activities, such as collaborative practice agreements.
Justifying clinical pharmacy services requires documenting interventions and demonstrating associated cost savings or cost avoidance.
Participation in interdisciplinary ICU rounds is proven to reduce adverse drug events and improve overall patient outcomes.
Last updated: July 2026
Professional Development, Precepting, and ICU Pharmacy Practice
Critical care pharmacists must balance advanced clinical duties with educational responsibilities, professional advocacy, and interdisciplinary collaboration. Maintaining high-quality ICU pharmacy services requires adhering to standardized training models, providing structured feedback, and securing institutional credentialing and privileging.
Precepting Pharmacy Students and Residents
Precepting is a core component of critical care practice. The American Society of Health-System Pharmacists (ASHP) residency accreditation standards establish rigorous guidelines for preceptor eligibility, demanding that preceptors demonstrate ongoing clinical competence, contributions to practice, and professional development.
The Four Roles of a Preceptor
Based on the situational leadership model, preceptors must transition through four distinct roles to guide a learner from dependency to independent practice:
Direct Instruction: Utilized at the beginning of a rotation or when introducing a complex, unfamiliar topic. The preceptor acts as the primary source of information, delivering key facts, guidelines, and expectations.
ICU Example: Explaining the receptor binding profiles of vasopressors and inotropes (e.g., alpha-1 vs. beta-1 vs. V1 receptors) to a student on their first day of a medical ICU rotation.
Modeling: The preceptor performs a clinical activity while "thinking out loud," allowing the learner to observe the cognitive processes, prioritization, and communication strategies of an experienced clinician.
ICU Example: The preceptor demonstrates how to review a patient's chart before ICU rounds, explaining why they prioritize fluid balance, antimicrobial culture dates, and sedation scores (RASS/CAM-ICU).
Coaching: The learner attempts the task while the preceptor directly observes and provides real-time guidance, redirection, and encouragement.
ICU Example: Watching a resident calculate a target phenytoin or vancomycin dose for a patient with acute brain injury, letting them work through the calculations, and correcting errors as they occur.
Facilitating: The learner works independently, managing a patient load and making clinical decisions. The preceptor steps back, acting as a consultant. The preceptor only intervenes if patient safety is compromised, and uses probing questions to encourage self-reflection.
ICU Example: Allowing a PGY2 critical care resident to independently lead pharmacy services on interdisciplinary ICU rounds, followed by a debrief session to discuss their interventions.
Feedback vs. Evaluation
Understanding the distinction between feedback and evaluation is essential for effective clinical education.
Feedback: Formative in nature. It is constructive, frequent, immediate, and diagnostic. The goal of feedback is to modify immediate clinical behaviors, correct errors, and guide the learner's development throughout the rotation. It should be delivered as close to the event as possible.
Evaluation: Summative in nature. It is scheduled (e.g., midpoint and final evaluations), formal, and evaluative. The goal of evaluation is to document the learner's cumulative performance and progress against established learning objectives (e.g., ASHP Educational Goals and Objectives).
Structuring Feedback in Clinical Education
Delivering constructive feedback requires structured, objective communication to minimize defensiveness and promote change.
Situation-Behavior-Impact (SBI) Model
The SBI framework focuses on observable facts rather than subjective personality judgments:
Situation: Define the specific context (time and place).
Behavior: Describe the specific, observable behavior (avoiding labels like "unprofessional" or "lazy").
Impact: Explain the consequence of the behavior on the patient, team, or workflow.
ICU Example: "During ICU rounds this morning on Patient X [Situation], you recommended discontinuing stress ulcer prophylaxis without checking if the patient was still mechanically ventilated [Behavior], which led the attending physician to question the pharmacy's recommendations and temporarily delayed rounds [Impact]."
Pendleton's Rules of Feedback
This model structures a collaborative conversation that prioritizes learner self-reflection:
The learner states what they did well.
The preceptor highlights what the learner did well.
The learner identifies what could be improved.
The preceptor details what can be improved and collaborates on an action plan.
Promoting Self-Reflection
Preceptors should use open-ended questions to build metacognitive skills:
- "What factors did you consider when selecting that antibiotic regimen?"
- "How do you feel your presentation to the attending physician went, and what would you alter next time?"
- Coaching Strategies for Clinical Reasoning
- The Five-Step Microskills (One-Minute Preceptor)
This model allows preceptors to teach efficiently during clinical rounds:
Get a Commitment: Ask the learner to make a clinical decision (e.g., "What is your assessment of this patient's acid-base status, and what should we do?").
Probe for Supporting Evidence: Ask the learner to explain their clinical reasoning (e.g., "What factors in the laboratory values and clinical history support your choice of sodium bicarbonate?").
Teach General Rules: Provide a brief clinical pearl or guideline-based rule (e.g., "Remember that in severe metabolic acidosis, we generally target a pH of > 7.2 > 7.2 > 7.2 rather than trying to normalize the bicarbonate level").
Reinforce What Was Done Right: Provide specific positive feedback (e.g., "You did an excellent job checking the patient's potassium level before suggesting we address the acidosis").
Correct Mistakes: Address areas of weakness and provide the correct approach (e.g., "Next time, make sure to calculate the anion gap first to help narrow down the differential diagnosis").
Collaborative Practice Agreements, Credentialing, and Privileging
As key members of the multidisciplinary team, critical care pharmacists must have their clinical roles formalized.
Collaborative Practice Agreements (CPAs)
CPAs are voluntary agreements between pharmacists and physicians that define a pharmacist's authority to manage drug therapy. Common ICU CPAs include:
Pharmacokinetics: Independently ordering, dosing, and monitoring drugs like vancomycin, aminoglycosides, and phenytoin.
Electrolyte Replacement: Protocol-driven correction of potassium, magnesium, and phosphorus.
Anticoagulation: Initiating, adjusting, and monitoring heparin infusions, warfarin, and direct oral anticoagulants.
Sedation/Analgesia: Titrating sedatives and analgesics based on target RASS and CPOT scores.
Credentialing and Privileging
Credentialing: The verification of a practitioner's professional qualifications, licenses, degrees, postgraduate training (PGY1 and PGY2 residencies), and certifications (such as Board Certified Critical Care Pharmacist [BCCCP]).
Privileging: The institutional authorization granted by a hospital's medical staff or governing body to perform specific clinical activities within that facility. Privileging ensures the pharmacist has demonstrated clinical competence to execute the duties outlined in a CPA.
Quality Review: Continued competency is monitored via Focused Professional Practice Evaluations (FPPE) for new privileges and Ongoing Professional Practice Evaluations (OPPE) for existing privileges.
Interprofessional Education (IPE) and Training in the ICU
The ICU is a high-stress, interdisciplinary environment where communication failures can lead to sentinel events. Pharmacists are uniquely positioned to design and lead IPE.
Designing Effective IPE Programs
Simulation-Based Training: Creating high-fidelity mock codes, septic shock resuscitation scenarios, or ventilator workshops where nurses, physicians, respiratory therapists, and pharmacists work together.
Case-Based Workshops: Interdisciplinary reviews of delirium management (using CAM-ICU and CPOT) or ICU sedation guidelines.
Nursing Education: Organizing inservices on vasoactive drug compatibility, administration rates, and side effect profiles.
Benefits: IPE fosters mutual respect, clarifies professional roles, improves communication during crises, and has been shown to reduce ICU medication errors and improve overall patient outcomes.